Literature DB >> 29196912

What is this image? 2017: Image 4 result : Improvement of ischemia with statin therapy.

Ronald G Schwartz1,2.   

Abstract

Entities:  

Year:  2018        PMID： 29196912     DOI： 10.1007/s12350-017-1143-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  10 in total

1.  Bone marrow: a fountain of vascular youth?

Authors:  Peter Libby
Journal:  Circulation       Date:  2003-07-29       Impact factor: 29.690

2.  Monitoring effectiveness of medical therapy in 2006.

Authors:  Ronald G Schwartz; Mark A Kudes
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

3.  Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.

Authors:  B G Brown; X Q Zhao; A Chait; L D Fisher; M C Cheung; J S Morse; A A Dowdy; E K Marino; E L Bolson; P Alaupovic; J Frohlich; J J Albers
Journal:  N Engl J Med       Date:  2001-11-29       Impact factor: 91.245

4.  Can single photon emission computed tomography myocardial perfusion imaging monitor the potential benefit of aggressive treatment of hyperlipidemia?

Authors:  R G Schwartz; T A Pearson
Journal:  J Nucl Cardiol       Date:  1997 Nov-Dec       Impact factor: 5.952

5.  Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial.

Authors:  Ronald G Schwartz; Thomas A Pearson; Vijay G Kalaria; Maria L Mackin; Daniel J Williford; Ashish Awasthi; Abrar Shah; Adam Rains; Joseph J Guido
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094

6.  Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.

Authors:  C B Treasure; J L Klein; W S Weintraub; J D Talley; M E Stillabower; A S Kosinski; J Zhang; S J Boccuzzi; J C Cedarholm; R W Alexander
Journal:  N Engl J Med       Date:  1995-02-23       Impact factor: 91.245

7.  Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium.

Authors:  K L Gould; J P Martucci; D I Goldberg; M J Hess; R P Edens; R Latifi; S J Dudrick
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

8.  Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification.

Authors:  K L Gould; D Ornish; L Scherwitz; S Brown; R P Edens; M J Hess; N Mullani; L Bolomey; F Dobbs; W T Armstrong
Journal:  JAMA       Date:  1995-09-20       Impact factor: 56.272

9.  Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse.

Authors:  G S Huggins; R C Pasternak; N M Alpert; A J Fischman; H Gewirtz
Journal:  Circulation       Date:  1998-09-29       Impact factor: 29.690

10.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.